Side-by-side comparison of AI visibility scores, market position, and capabilities
Nigeria YC W23 automotive dealer fintech with $56M transactions across 1,400+ dealers at $2M+ ARR Nov 2023; $7M+ total ($3.2M Ventures Platform/MaC/YC equity + $4M+ debt) competing with AutoChek for $30B African used car market dealer financing.
Shekel Mobility is a Lagos, Nigeria-based B2B automotive fintech platform — backed by Y Combinator (W23) with $7 million+ in total funding including $3.2 million in equity and $4 million+ in debt in November 2023 co-led by Ventures Platform and MaC Venture Capital with participation from Y Combinator, Voltron Capital, and Zedcrest — providing African car dealers with a combined marketplace, neobank, and trading platform that enables inventory financing, dealer payments, and business banking for the $30 billion African used car market. Founded in 2022, Shekel generated $2 million+ in ARR by November 2023, facilitated $56 million in transactions across 1,400+ auto dealers, and financed 7,000 cars through Shekel Credit (providing up to $200,000 credit limits per dealer) with a 2025 goal of facilitating $10 billion in annual automotive transactions.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.